dc.contributor.author | Schifano, Fabrizio | |
dc.contributor.author | Corkery, John | |
dc.contributor.author | Ghodse, A.Hamid | |
dc.date.accessioned | 2012-12-06T13:00:20Z | |
dc.date.available | 2012-12-06T13:00:20Z | |
dc.date.issued | 2012-10 | |
dc.identifier.citation | Schifano , F , Corkery , J & Ghodse , A H 2012 , ' Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, meow meow) in the United Kingdom ' , Journal of Clinical Psychopharmacology , vol. 32 , no. 5 , pp. 710-714 . https://doi.org/10.1097/JCP.0b013e318266c70c | |
dc.identifier.issn | 0271-0749 | |
dc.identifier.uri | http://hdl.handle.net/2299/9322 | |
dc.description | Copyright 2012 Elsevier B.V., All rights reserved. | |
dc.description.abstract | Background: International media have been reporting about fatalities allegedly related to mephedrone, a popular recreational stimulant, but now a proportion of them have been confirmed. We aimed here at analyzing information relating to the circumstances of mephedrone-related deaths in the United Kingdom. Methods: Descriptive analysis of information was mainly extracted from the UK National Programme on Substance Abuse Deaths database. With an average annual response rate of 95%, UK National Programme on Substance Abuse Deaths receives information from coroners on drug-related deaths among both addicts and nonaddicts in the United Kingdom, the Channel Islands, and the Isle of Man. RESULTS: So far, 128 alleged mephedrone-associated fatalities have been reported; mephedrone was identified at postmortem in 90 cases; inquests have been concluded in 69 cases, 62 of which are analyzed here. Typical mephedrone victims were young (mean age, 28.8 years), male, and with a previous history of drug misuse. There was a notable number (18 cases [29%], 11 being from hanging) of deaths involving self-harm. Mephedrone alone was identified at postmortem on 8 occasions (13% of the inquests' sample). Conclusions: Present mortality data may suggest a significant level of caution when ingesting mephedrone. Limitations include an inability to determine the exact extent of risks associated with mephedrone consumption | en |
dc.format.extent | 5 | |
dc.format.extent | 150161 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Clinical Psychopharmacology | |
dc.title | Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, meow meow) in the United Kingdom | en |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1097/JCP.0b013e318266c70c | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |